Acquisition Pivots this Firm to Psychedelic Drug Development
January 20 2022 - 2:18PM
AllPennyStocks.com
The exploration of psychedelics for mental health treatment is a
growing opportunity and this firm is ceasing its current operations
to focus on drug development with its new acquisition.
...
To read the full story on AllPennyStocks.com, click
here.
Blue Water Ventures (CE) (USOTC:BWVI)
Historical Stock Chart
From Feb 2025 to Mar 2025
Blue Water Ventures (CE) (USOTC:BWVI)
Historical Stock Chart
From Mar 2024 to Mar 2025